Finlay Institute

ACTIVE

新泽西州哈德逊县, New Jersey, United Stateswww.finlaymedical.comPrivate1–10 employeesEstablished: 2011-01-01

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2011

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

25.0%

Not Applicable

12.5%

Phase 4

12.5%

Trial Status Distribution

Completed

100.0%

Clinical Trials

Trials sponsored by this organization (8)

Phase I-II study of live oral cholera vaccine 638 in healthy adult volunteers in Cuba.

Phase 1

Completed

interventional

Sep 200848 participants

Phase Ib-IIb trial of the live oral cholera vaccine 638 in adult volunteers in Mozambique.

Phase 1

Completed

interventional

Sep 2008120 participants

Challenge study to determine the protective efficacy of a single oral dose of the attenuated 638 strain.

Not Applicable

Completed

interventional

Sep 200827 participants

A phase I/II study to evaluate the Salmonella Typhi Vi polysaccharide vaccine – vax-TyVi – in children and teenagers.

A phase II study of the Cuban adult formulation tetanus and diphtheria vaccine.

Phase 2

Completed

interventional

Jul 2008225 participants

Post marketing clinical trial to evaluate the reactogenicity profile of the Cuban vaccine against diphtheria, tetanus, and pertussis infections in infants.

Phase 4

Completed

interventional

Jul 200857 participants

Clinical trial to evaluate the safety, reactogenicity and immunogenicity of the vax-TyVi vaccine in volunteers between 18 and 20 years of age.

A phase II study of the Cuban vaccine against tetanus and diphtheria VA-DIFTET.

Phase 2

Completed

interventional

Jul 2008300 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations